In June 2021, the FDA approved Wegovy for chronic weight management for adults with obesity (BMI 30kg/m2) or overweight (BMI 27kg/m2) and related comorbidities with at least one weight-related comorbidity, to be administered subcutaneously at 2.4mg once weekly
A vegan diet may lower systemic inflammation, a known driver of brain issues
Boeri L, Capogrosso P, Salonia A
Individual providers maintain valid state medical licenses and malpractice insurance
The answer, under appropriate medical supervision, often leans towards a promising yes, due to their distinct yet reinforcing effects: Enhanced Metabolic Efficiency and Appetite Control GLP-1 RAs primarily work by regulating appetite, slowing gastric emptying, and improving glucose homeostasis, which leads to reduced calorie intake and better blood sugar control
10.1038/s41568-022-00459-0 71 LeuJ